SCHEMBL27615952

SCHEMBL27615952

CC(C)CNc1cc(NC(=O)O)c(N)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 4/20 0.42
KDM6B O15054 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
HPGD P15428 5/20 0.35
ATM Q13315 1/20 0.35
PDK1 Q15118 2/20 0.35
PDK2 Q15119 2/20 0.35
PDK3 Q15120 2/20 0.35
PDK4 Q16654 2/20 0.35
HDAC1 Q13547 1/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ESR1 P03372 1/20 0.34
ALDH1A1 P00352 3/20 0.34
GAA P10253 2/20 0.34
MAPT P10636 2/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5562128 0.82 AAK1 (0.44) MEN1TSHRKMT2AKDM4EPDK1
SCHEMBL27615897 0.80 AR (0.42) MEN1TSHRKMT2AKDM6BKDM4C
SCHEMBL27615843 0.79 MAPT (0.44) MEN1TSHRKMT2ALMNAALDH1A1
SCHEMBL6608117 0.76 PTGER4 (0.47) KDM4EKDM4CHDAC1NPC1RAB9A
SCHEMBL1726529 0.75 PRKCI (0.41) MEN1KMT2AKDM4EHPGDHDAC1
SCHEMBL27597105 0.75 CD44 (0.52) MEN1KMT2AKDM4EHPGDHDAC1
SCHEMBL27597109 0.74 PTGS2 (0.44) MEN1TSHRKMT2AKDM4ELMNA
SCHEMBL27597171 0.72 CD44 (0.52) MEN1KMT2AKDM4EHPGDHDAC1
SCHEMBL27597110 0.71 ALDH1A1 (0.33) MEN1KMT2AKDM4EHDAC1ALDH1A1
SCHEMBL27539460 0.70 TSHR (0.38) MEN1TSHRKMT2AKDM4EKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497333-C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2009-06-10 CN disclosed
CN-1633430-A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed